skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors

Original Research

(3212) Views  (1146) Full article downloads

Authors: M Gabrovska, F Geurs, S Ponette, et al

Published Date October 2009 Volume 2009:1 Pages 9 - 12
DOI: http://dx.doi.org/10.2147/HMER.S7574

M Gabrovska,1 F Geurs,1 S Ponette,2 J Ponette,2 K Bulte,2 L Derveaux,3 I Kempeneers4

1Depts of Medical Oncology, 2Gastroenterology, 3Pneumology and 4Surgery, Regionaal Ziekenhuis Sint Maria, Halle, Belgium

Abstract: Few data are available on patient management in jaundice caused by liver metastases of solid tumors (nonbreast and noncolon origin). We report the first patient series consecutively treated with cisplatin weekly in patients with severe jaundice and liver failure due to underlying metastatic neoplasms. In 4 out of 8 cases, liver function tests were reversed and jaundice disappeared, permitting subsequent standard chemotherapy. The other 4 patients died 3 to 5 weeks after admission, illustrating the extent and severity of the underlying neoplasm.

Keywords: liver failure, jaundice, metastases, chemotherapy, cisplatin






 

Other articles by Dr Filip Geurs



Readers of this article also read:

A high prevalence of extreme hyperferritinemia in acute hepatitis patients
Cyclic AMP-guanine exchange factor activation inhibits JNK-dependent lipopolysaccharide-induced apoptosis in rat hepatocytes
Insulin-like growth factor binding protein-3 is required for the regulation of rat oval cell proliferation and differentiation in the 2AAF/PHX model
Mechanism of the inhibitory effect of ghrelin in sepsis
Liver stiffness: a novel parameter for the diagnosis of liver disease
Optimal management of hepatorenal syndrome in patients with cirrhosis
A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection
Relationship between serum HBsAg level, HBV DNA level, and peripheral immune cells in patients with chronic hepatitis B virus infection
Update on new approaches in the management of hepatocellular carcinoma
Pathogenesis and management of alcoholic liver cirrhosis: a review
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio